Review



exosome mirna expression profiles  (Exosome Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Exosome Diagnostics exosome mirna expression profiles
    Exosome Mirna Expression Profiles, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+mirna+expression+profiles/pmc12769645-571-0-0?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    exosome mirna expression profiles - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    exosome mirna expression profiles  (Exosome Diagnostics)
    86
    Exosome Diagnostics exosome mirna expression profiles
    Exosome Mirna Expression Profiles, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+mirna+expression+profiles/pmc12769645-571-0-0?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    exosome mirna expression profiles - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    exosomal lncrna, mirna & mrna expression profiles  (Epigenomics ag)
    90
    Epigenomics ag exosomal lncrna, mirna & mrna expression profiles
    Exosomal Lncrna, Mirna & Mrna Expression Profiles, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+mirna+expression+profiles/pm32462942-553-11-1?v=Epigenomics+ag
    Average 90 stars, based on 1 article reviews
    exosomal lncrna, mirna & mrna expression profiles - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    genome-wide expression profiling of exosomal mirnas  (Illumina Inc)
    90
    Illumina Inc genome-wide expression profiling of exosomal mirnas
    Expression of seven Significantly Deregulated <t> miRNAs </t> Between Localized PCa Patients and Metastatic PCa Patients Determined by NGS Technology
    Genome Wide Expression Profiling Of Exosomal Mirnas, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+mirna+expression+profiles/pmc07797303-149-5-9?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    genome-wide expression profiling of exosomal mirnas - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of seven Significantly Deregulated miRNAs Between Localized PCa Patients and Metastatic PCa Patients Determined by NGS Technology

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Expression of seven Significantly Deregulated miRNAs Between Localized PCa Patients and Metastatic PCa Patients Determined by NGS Technology

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: Expressing

    Expression of Significantly Deregulated miRNAs Between PCa Patients and Healthy Controls Determined by NGS Technology

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Expression of Significantly Deregulated miRNAs Between PCa Patients and Healthy Controls Determined by NGS Technology

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: Expressing, Control

    Expression of 5 candidate exosomal miRNAs in the urine samples of the validation cohort. Relative expression levels of urinary exosomal miR-375 ( A ), miR-16-2-3p ( B ), miR-486-3p ( C ), miR-451a ( D ), and miR-486-5p ( E ) in patients with PCa. Data presented as relative fold changes.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Expression of 5 candidate exosomal miRNAs in the urine samples of the validation cohort. Relative expression levels of urinary exosomal miR-375 ( A ), miR-16-2-3p ( B ), miR-486-3p ( C ), miR-451a ( D ), and miR-486-5p ( E ) in patients with PCa. Data presented as relative fold changes.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: Expressing, Biomarker Discovery

    Receiver operator characteristic curve (ROC) for 4 individual miRNAs (miR-375, miR-451a, miR-486-3p and miR-486-5p) and their combination to differentiate between PCa patients and healthy controls.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Receiver operator characteristic curve (ROC) for 4 individual miRNAs (miR-375, miR-451a, miR-486-3p and miR-486-5p) and their combination to differentiate between PCa patients and healthy controls.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques:

    Expression of urinary exosomal miRNAs in PCa patients and BPH patients. Relative expression levels of urinary exosomal miR-375 ( A ), miR-451a ( B ), miR-486-3p ( C ), and miR-486-5p ( D ). Data are presented as relative fold changes.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Expression of urinary exosomal miRNAs in PCa patients and BPH patients. Relative expression levels of urinary exosomal miR-375 ( A ), miR-451a ( B ), miR-486-3p ( C ), and miR-486-5p ( D ). Data are presented as relative fold changes.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: Expressing

    Evaluation of the ability of the miRNA-based panel and PSA to differentiate between patients with PCa and patients with BPH. Receiver operator characteristic (ROC) curve for PSA, two individual miRNAs (miR-375 and miR-451a) and their combination to differentiate between two groups consisting of 47 PCa patients and 29 BPH patients.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Evaluation of the ability of the miRNA-based panel and PSA to differentiate between patients with PCa and patients with BPH. Receiver operator characteristic (ROC) curve for PSA, two individual miRNAs (miR-375 and miR-451a) and their combination to differentiate between two groups consisting of 47 PCa patients and 29 BPH patients.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques:

    Expression of urinary exosomal miRNAs in localized PCa and metastatic PCa. Relative expression levels of urinary exosomal miR-375 ( A ), miR-451a ( B ), miR-486-3p ( C ), and miR-486-5p ( D ) in localized PCa patients and metastatic PCa patients. Data presented as relative fold changes.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Expression of urinary exosomal miRNAs in localized PCa and metastatic PCa. Relative expression levels of urinary exosomal miR-375 ( A ), miR-451a ( B ), miR-486-3p ( C ), and miR-486-5p ( D ) in localized PCa patients and metastatic PCa patients. Data presented as relative fold changes.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: Expressing

    Receiver-operating characteristic curve (ROC) for urinary exosomal miR-375 and PSA to differentiate between localized PCa patients and metastatic PCa patients.

    Journal: Cancer Management and Research

    Article Title: Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

    doi: 10.2147/CMAR.S272140

    Figure Lengend Snippet: Receiver-operating characteristic curve (ROC) for urinary exosomal miR-375 and PSA to differentiate between localized PCa patients and metastatic PCa patients.

    Article Snippet: A genome-wide expression profiling of exosomal miRNAs obtained by Illumina NGS technology showed that urine from PCa patients had 39 down-regulated miRNAs and 14 up-regulated miRNAs compared with urine from the healthy controls , and urine from metastatic PCa patients had 7 down-regulated miRNAs compared with the urine of localized PCa patients ( ).

    Techniques: